Miyoshi, A., Kameda, H., Nagai, S., Nakamura, A., Miya, A., Takase, T., . . . Miyoshi, H. (2020). Beneficial effects of switching to denosumab from bisphosphonates or selective estrogen receptor modulators in postmenopausal women with type 2 diabetes and osteopenia/osteoporosis. J Diabetes Investig.
Citación estilo ChicagoMiyoshi, Arina, Hiraku Kameda, So Nagai, Akinobu Nakamura, Aika Miya, Takahiro Takase, Tatsuya Atsumi, and Hideaki Miyoshi. "Beneficial Effects of Switching to Denosumab From Bisphosphonates or Selective Estrogen Receptor Modulators in Postmenopausal Women With Type 2 Diabetes and Osteopenia/osteoporosis." J Diabetes Investig 2020.
Cita MLAMiyoshi, Arina, et al. "Beneficial Effects of Switching to Denosumab From Bisphosphonates or Selective Estrogen Receptor Modulators in Postmenopausal Women With Type 2 Diabetes and Osteopenia/osteoporosis." J Diabetes Investig 2020.